Perturbations in these pathways may impair the IFN response against SARS‐CoV‐2 and explain persistent blood viral load and an exacerbated inflammatory response in COVID‐19 patients (Hadjadj et al, 2020). The gene discussed is IFNA1; the disease is COVID-19.